Daniel Wagner
Board Director
Diagnostic Platform
IsoPlexis
United States of America
Biography
Dan serves as a Managing Director of Investments at Connecticut Innovations and is an active board member of multiple life sciences companies. Dan contributes to CI’s expertise in biotech with more than 10 years in the industry. He was previously employed by CuraGen Corporation, where he held a variety of scientific and operational management positions. He holds an M.B.A. and M.H.S. degree in Biomedical Sciences from Quinnipiac University, and a B.S. degree in Biology from the University of Dayton.
Research Interest
Accelerating the fight against cancer and a range of our toughest diseases by producing the world’s most precise detection systems
